ADC Therapeutics S.A.

ADCT · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$250,867$278,598$326,441$466,544
Short-Term Investments$0$0$0$0
Receivables$20,316$25,182$72,971$32,166
Inventory$18,387$16,177$12,073$11,122
Other Curr. Assets$17,820$16,334$23,495$15,350
Total Curr. Assets$307,390$336,291$434,980$525,182
Property Plant & Equip (Net)$13,429$16,133$10,260$11,230
Goodwill$0$0$0$0
Intangibles$0$0$14,360$13,582
Long-Term Investments$0$1,647$7,613$41,236
Tax Assets$0$0$37,104$26,049
Other NC Assets$1,161$711-$13,458$693
Total NC Assets$14,590$18,491$55,879$92,790
Other Assets$0$0$0$0
Total Assets$321,980$354,782$490,859$617,972
Liabilities
Payables$18,029$15,569$12,351$12,080
Short-Term Debt$1,371$1,467$13,571$7,604
Tax Payable$0$0$0$3,754
Deferred Revenue$0$0$0$0
Other Curr. Liab.$61,069$50,634$56,017$50,497
Total Curr. Liab.$80,469$67,670$81,939$73,935
LT Debt$121,627$122,910$116,278$132,094
Deferred Rev, NC$320,093$0$23,539$23,539
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,433$312,451$189,652$222,316
Total NC Liab.$444,153$435,361$329,469$377,949
Other Liabilities$0$0$0$0
Cap. Leases$9,366$11,647$7,661$8,023
Total Liabilities$524,622$503,031$411,408$451,884
Equity
Pref Stock$0$0$0$0
Common Stock$8,425$7,312$7,312$6,445
Retained Earnings-$1,493,318-$1,335,472-$1,095,419-$924,885
AOCI-$1,421-$93$1,823$102,829
Other Equity$1,283,672$1,180,004$1,165,735$981,699
Total Equity-$202,642-$148,249$79,451$166,088
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$321,980$354,782$490,859$617,972
Net Debt-$127,869-$154,221-$196,592-$326,846
ADC Therapeutics S.A. (ADCT) Financial Statements & Key Stats | AlphaPilot